Going Beyond PDL-1. Q&A with Dr. Nina Radosevic- Robin, MD.

Dr. Nina Radosevic-Robin, MD, is a Board-Certified Surgical/Molecular Pathologist at Centre Jean Perrin, a Sr. Scientist within the Unit 1240 of French National Institute for Medical Research (INSERM), and a Lecturer in Molecular Oncology and Protein Science at the University...

/ June 22, 2020

Why is Digital Spatial Profiling Critical to Studying Sarcomas? Q&A with Dr. Troy McEachron, Ph.D

“Whereas the EWS specimens tended to have very simple genomes, the osteosarcoma specimens looked like a hand grenade had gone off in the genome. These were the most fragmented and complex genomes I had ever seen”. Troy McEachron, Ph.D The first...

/ June 15, 2020

Solid Organ Transplantation and the Immunology of Rejection. Q&A with GeoMx® Digital Spatial Profiler Grant Winner Dr. Fadi Issa

"Cancer immunotherapy and transplantation are basically the same field; one’s just the flip side of the other". Dr. Fadi Issa Have you ever been to Oxford? Situated in the gorgeous English countryside, 56 miles northwest of London, Oxford is the...

/ June 8, 2020

Searching for New Biomarkers to Prevent Organ Transplant Rejection. Q&A with HOT Panel Grant Winner Dr. Evan Farkash

Bob’s first question to me was: “How much do you want to learn about kidney pathology?” My response was that I wanted to learn as much as I could, and I don’t think I have stopped learning since then.” Dr....

/ June 1, 2020

Spotlight on a CRO. Q&A with Dr. Edward J. Weinstein, Ph.D., CEO and co-founder of Canopy BioSciences.

There is a lot to love in the beautiful city of St. Louis: from the quiet neighborhoods permeated with old world charm to the picturesque streets reminiscent of Paris “petites rues” ─ St. Louis was after all founded by a...

/ May 25, 2020